TY - JOUR
T1 - Comparison of brain structural variables, neuropsychological factors, and treatment outcome in early-onset versus late-onset late-life depression
AU - Disabato, Brianne M.
AU - Morris, Carrie
AU - Hranilovich, Jennifer
AU - D'Angelo, Gina M.
AU - Zhou, Gongfu
AU - Wu, Ningying
AU - Doraiswamy, P. Murali
AU - Sheline, Yvette I.
N1 - Funding Information:
Supported by grants to the Alzheimer's Disease Research Center ( P50AG05681 ) and Healthy Aging and Senile Dementia Project ( P01AG03991 ), a grant to the WUSM General Clinical Research Center ( RR00036 ), and grants ( 1 UL1 RR024992-01 , 1 TL1 RR024995-01 , and 1 KL2 RR 024994-01 ) from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. Information on NCRR is available at http://www.ncrr.nih.gov/ . Information on Re-engineering the Clinical Research Enterprise can be obtained from http://nihroadmap.nih.gov/clinicalresearch/overview-translational.asp .
Funding Information:
Dr. Sheline received support through the Collaborative R01 for Clinical Studies of Mental Disorders ( MH60697 ), support from National Institute of Mental Health ( K24 65421 ), and a grant from Pfizer, Inc. to pay for drug costs. Dr. Doraiswamy received support through the Collaborative R01 for Clinical Studies of Mental Disorders ( MH62158 ) for this study. Dr. Doraiswamy also received research grants and speaking/advisory fees from several pharmaceutical and diagnostic companies, including makers of antidepressants for other studies, and owns stock in Clarimedix, AdverseEvents, and Sonexa, whose products are not discussed here. Dr. Disabato received expert testimony support through Bauer & Baebler. Ms. Hranilovich received grant and travel support through National Institute of Mental Health funding (M-STREAM). For the remaining authors, no conflicts and/or sources of funding were declared.
Publisher Copyright:
© 2014 American Association for Geriatric Psychiatry.
PY - 2014/10/1
Y1 - 2014/10/1
N2 - Objective To compare differences in gray matter volumes, white matter and subcortical gray matter hyperintensities, neuropsychological factors, and treatment outcome between early-and late-onset late-life depressed (LLD) subjects. Methods We conducted a prospective, nonrandomized, controlled trial at the outpatient clinics at Washington University and Duke University on 126 subjects, aged 60 years or older, who met Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria for major depression, scored 20 or more on the Montgomery-Asberg Depression Rating Scale (MADRS), and received neuropsychological testing and magnetic resonance imaging. Subjects were excluded for cognitive impairment or severe medical disorders. After 12 weeks of sertraline treatment, subjects' MADRS scores over time and neuropsychological factors were studied. Results Left anterior cingulate thickness was significantly smaller in the late-onset depressed group than in the early-onset LLD subjects. The late-onset group also had more hyperintensities than the early-onset LLD subjects. No differences were found in neuropsychological factor scores or treatment outcome between early-onset and late-onset LLD subjects. Conclusion Age at onset of depressive symptoms in LLD subjects are associated with differences in cortical thickness and white matter and subcortical gray matter hyperintensities, but age at onset did not affect neuropsychological factors or treatment outcome.
AB - Objective To compare differences in gray matter volumes, white matter and subcortical gray matter hyperintensities, neuropsychological factors, and treatment outcome between early-and late-onset late-life depressed (LLD) subjects. Methods We conducted a prospective, nonrandomized, controlled trial at the outpatient clinics at Washington University and Duke University on 126 subjects, aged 60 years or older, who met Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria for major depression, scored 20 or more on the Montgomery-Asberg Depression Rating Scale (MADRS), and received neuropsychological testing and magnetic resonance imaging. Subjects were excluded for cognitive impairment or severe medical disorders. After 12 weeks of sertraline treatment, subjects' MADRS scores over time and neuropsychological factors were studied. Results Left anterior cingulate thickness was significantly smaller in the late-onset depressed group than in the early-onset LLD subjects. The late-onset group also had more hyperintensities than the early-onset LLD subjects. No differences were found in neuropsychological factor scores or treatment outcome between early-onset and late-onset LLD subjects. Conclusion Age at onset of depressive symptoms in LLD subjects are associated with differences in cortical thickness and white matter and subcortical gray matter hyperintensities, but age at onset did not affect neuropsychological factors or treatment outcome.
KW - Late-life depression
KW - age at onset
KW - amygdala
KW - antidepressant
KW - cognitive deficit
KW - hippocampus
KW - neuropsychological factors
KW - treatment outcome
KW - vascular risk factors
KW - white matter hyperintensities
UR - http://www.scopus.com/inward/record.url?scp=84909587654&partnerID=8YFLogxK
U2 - 10.1016/j.jagp.2013.02.005
DO - 10.1016/j.jagp.2013.02.005
M3 - Article
C2 - 23768683
AN - SCOPUS:84909587654
VL - 22
SP - 1039
EP - 1046
JO - American Journal of Geriatric Psychiatry
JF - American Journal of Geriatric Psychiatry
SN - 1064-7481
IS - 10
ER -